Ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and preparation method of cubic liquid crystal nanoparticles

A technology of liquid crystal precursors and nanoparticles, applied in the field of cubic liquid crystal nanoparticles and its preparation, ibuprofen cubic liquid crystal precursor solution, can solve the problems of low solubility, short half-life, etc., achieve strong hydrophobicity, poor water solubility, overcome Effects of Disorders of Dissolution

Inactive Publication Date: 2017-05-24
GUANGZHOU ZHONGDA NANSHA TECH INNOVATION IND PARK +1
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Based on this, the present invention provides a kind of ibuprofen cubic liquid crystal precursor solution, is used for preparing the ibuprofen cubic liquid crystal nanoparticle that is used for oral administration, to overcome the low solubility of ibuprofen in oral administration process, short half-life in vivo Disadvantages to improve oral bioavailability of ibuprofen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and preparation method of cubic liquid crystal nanoparticles
  • Ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and preparation method of cubic liquid crystal nanoparticles
  • Ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and preparation method of cubic liquid crystal nanoparticles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] The preparation method of the ibuprofen cubic liquid crystal nanoparticles of the present embodiment comprises the following steps:

[0053] Weigh ibuprofen, F127 and phytantriol according to the raw material prescription shown in Table 1, place them in a 100mL plastic centrifuge tube, heat and melt in a water bath at 60°C, vortex, mix well, and place at room temperature for 2 days to obtain Ibuprofen Cubic Liquid Crystal Precursor Solution.

[0054] Add 30mL of water to the ibuprofen cubic liquid crystal precursor solution, carry out ultrasonic dispersion with an ultrasonic pulverizer, the time is 10min, the ultrasonic power used is 200W, the ultrasonic working time is 5s, and the intermittent time is 10s to obtain the ibuprofen cubic liquid crystal coarse dispersion solution , the particle size distribution in the coarsely dispersed solution is uneven, and there are micron-sized particles (see figure 1 ).

[0055] The ibuprofen cubic liquid crystal coarse dispersion...

Embodiment 2

[0065] With the raw material prescription shown in Table 2, according to the preparation method of Example 1, prepare ibuprofen cubic liquid crystal nanoparticle solutions with different stabilizer types and dosages.

[0066] Measure the particle diameter of the ibuprofen cubic liquid crystal nanoparticles prepared in this embodiment, and the measurement method is the same as in Example 1, and judge its stability by comparing the particle diameter and PDI of the ibuprofen cubic liquid crystal nanoparticles on the 1st day and the 3rd day . see results Figure 5 , Table 2 and Table 3. As can be seen from the results, in the absence of a stabilizer, the nanoparticles are prone to aggregation and the particle size increases; the effect of the ibuprofen cubic liquid crystal coarse dispersion solution prepared by different amounts of F68 (poloxamer 188) is not good enough, and it is easy to agglomerate and the ibuprofen cubic liquid crystal coarse dispersion solution prepared by d...

Embodiment 3

[0073] Take ibuprofen, phytantriol and F127 by mass ratio 12:100:10, prepare ibuprofen cubic liquid crystal nanoparticles according to the method of Example 1, the difference is that the homogeneous pressure adopted is 670bar, 800bar, 1200bar and 1500bar; Homogenization times are 3, 5 and 9 times respectively.

[0074] Measure the ibuprofen cubic liquid crystal nanoparticles prepared in this embodiment, and the determination method is the same as that in Example 1. The results are shown in Table 4. The result shows, under the condition of different homogenization pressure and number of times, ibuprofen cubic liquid crystal nano-particle all has smaller particle diameter and PDI, wherein, when homogenization pressure is 1200bar, when homogenization number of times is 9 times, particle diameter minimum. Therefore, the optimal conditions for the high-pressure homogenization of ibuprofen cubic liquid crystal nanoparticles are: homogenization pressure 1200 bar, homogenization cyc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to an ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and a preparation method of the cubic liquid crystal nanoparticles. The ibuprofen cubic liquid crystal precursor solution is mainly prepared from ibuprofen, a liquid crystal material and a stabilizer, wherein a mass ratio of the ibuprofen to the liquid crystal material to the stabilizer is (0.01-2.5):(10):(0.5-2.5); the liquid crystal material is phytantriol; and the stabilizer is selected from at least one of fatty glyceride, polyol type nonionic surfactants, polyoxyethylene type nonionic surfactants, poloxamer and lecithin. The ibuprofen cubic liquid crystal precursor solution is prepared into ibuprofen cubic liquid crystal nanoparticles used for oral administration, and the defects such as low solubility and short half-life in vivo in the oral administration process of ibuprofen can be overcome, so that the bioavailability of oral administration of ibuprofen can be obviously improved.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to an ibuprofen cubic liquid crystal precursor solution, cubic liquid crystal nanoparticles and a preparation method thereof. Background technique [0002] Ibuprofen (IBU) is a non-steroidal anti-inflammatory drug with good antipyretic, analgesic and anti-inflammatory effects. For the relief of mild to moderate pain such as headache, joint pain, migraine, toothache, muscle pain, neuralgia, dysmenorrhea. It is also used for fever caused by the common cold or influenza. [0003] Ibuprofen belongs to Class II drugs of the biopharmaceutical classification system, with low solubility and high permeability. Drug dissolution is the rate-limiting stage of its absorption, which seriously affects the oral bioavailability of the drug. In addition, the biological half-life of ibuprofen is short (~1.8h). In order to maintain an effective therapeutic concentration, patients need to t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/127A61K47/10A61K31/192A61P29/00
CPCA61K47/10A61K9/0002A61K9/0053A61K9/1274A61K31/192
Inventor 吴传斌梅丽玲潘昕黄莹陈锦填典灵辉陈航平
Owner GUANGZHOU ZHONGDA NANSHA TECH INNOVATION IND PARK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap